摘要 |
<p>The invention provides one or more chemical entities selected from a compound of formula (I): wherein R<1> represents C1-6alkyl, C1-6alkoxy, trifluoromethyl, trifluoromethoxy, halo, cyano, 5-methyl-1,2,4-oxadiazol-3-yl or a group -SO2X; R<2> represents hydrogen, C1-6alkyl, C1-6alkoxy, halo or cyano; X is C1-6alkyl, -NR<3>R<4> or morpholino; R<3> and R<4> independently represent hydrogen or C1-6alkyl; and a pharmaceutically acceptable salt and solvate thereof; with the proviso that the compound {8-[4-(4-fluoro-benzyl)-benzenesulfonyl]-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl}-dimethyl-amine is excluded. The compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof are useful in therapy, in particular as antipsychotic agents.</p> |
申请人 |
GLAXO GROUP LIMITED;FORBES, IAN, THOMSON;GENTILE, GABRIELLA;GRIBBLE, ANDREW, DERRICK;LIGHTFOOT, ANDREW, P.;PAYNE, ANDREW, H.;SMITH, ALEXANDER, BAXTER |
发明人 |
FORBES, IAN, THOMSON;GENTILE, GABRIELLA;GRIBBLE, ANDREW, DERRICK;LIGHTFOOT, ANDREW, P.;PAYNE, ANDREW, H.;SMITH, ALEXANDER, BAXTER |